MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock... Read more
Basel, 12 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional supply of Regeneron’s casirivimab and imdevimab antibody cocktail for use in non-hospitalised COVID-19 patients as part of Operation Warp Speed. The US government... Read more
Tue 12th January 2021 Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale, and... Read more
Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute CHELMSFORD, Mass., Jan. 12, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that GENEWIZ, the Company’s genomics analysis business, has been awarded one of six Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI,... Read more
JANUARY 12, 2021COMPANY, LIBS, NEWS & PRESS, XRF SciAps, Inc. a Boston-based company specializing in handheld analytical instrumentation, is pleased to announce that Mr. Vito Angona has joined the company in the role of Managing Director, Germany, Austria and Switzerland (the “DACH” countries). SciAps will be opening a German-based subsidiary SciAps Germany in Krefeld, just outside of Dusseldorf.... Read more
The Center for Applied Quantum Technology (ZAQuant) receives the world’s first ZEISS GeminiSEM 560 installation The precise measurement of physical quantities is a driving force for almost all technical progress. The key mission at the Center for Applied Quantum Technology (ZAQuant) at the University of Stuttgart (Germany) is the development of novel quantum sensors for... Read more
01/12/2021 | Press Release In addition to the Automotive segment, the new president of HORIBA Europe GmbH Dr. Robert Plank is now also responsible for the Process & Environmental, Scientific and Semiconductor segments HORIBA today appointed Dr. Robert Plank as the new President of HORIBA Europe GmbH with effect from January 1st, 2021. Previously leading the group’s... Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue Fourth Quarter Earnings Call Scheduled for February 8, 2021 AUSTIN, Texas, Jan. 12, 2021 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced 4th quarter 2020 revenue of approximately $111M, up... Read more